Kadmon Corporation to Present at Two Upcoming Investor Conferences

Kadmon Corporation to Present at Two Upcoming Investor Conferences

ID: 355341

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 11/25/14 -- Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present an overview of Kadmon and its clinical and commercial programs at two upcoming investor conferences:

26th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3rd at 9:50 a.m. ET in New York City

25th Annual Oppenheimer Healthcare Conference on Thursday, December 11th at 11:30 a.m. ET in New York City

A live audio webcast of the Oppenheimer presentation will be accessible through the conference website at . The webcast will be archived for 90 days.

Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in oncology, immunological and neurologic diseases and fibrosis, monogenic diseases and metabolic disease. For more information, visit .

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.



Ellen Tremaine
Investors
646.490.2989


David Pitts
Argot Partners
212.600.1902



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  ScripsAmerica Highlights CEO Interviews From Recent Investor Conference Atossa Genetics to Present at Upcoming Investor Conferences and Events in December, 2014
Bereitgestellt von Benutzer: Marketwired
Datum: 25.11.2014 - 15:30 Uhr
Sprache: Deutsch
News-ID 355341
Anzahl Zeichen: 0

contact information:
Town:

NEW YORK, NY



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 255 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at Two Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von

Kadmon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Kadmon Issues Statement on Rosenfeld Lawsuit ...

NEW YORK, NY -- (Marketwired) -- 06/23/16 -- Kadmon Corporation, LLC today issued the following statement in response to a press release issued on June 22, 2016 from counsel for plaintiff Steven Rosenfeld, regarding the action he commenced on Februa ...

Alle Meldungen von Kadmon Corporation



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z